TRxADE HEALTH (NASDAQ:MEDS) Shares Down 0.1%

TRxADE HEALTH, Inc. (NASDAQ:MEDS) traded down 0.1% during mid-day trading on Monday . The company traded as low as $7.01 and last traded at $7.30. 5,917 shares traded hands during trading, a decline of 98% from the average session volume of 379,014 shares. The stock had previously closed at $7.31.

TRxADE HEALTH Stock Performance

The business has a 50 day simple moving average of $12.08 and a 200-day simple moving average of $7.88. The stock has a market capitalization of $8.83 million, a P/E ratio of -1.05 and a beta of 2.00.

TRxADE HEALTH (NASDAQ:MEDS) last issued its quarterly earnings results on Tuesday, January 16th. The company reported ($0.07) earnings per share (EPS) for the quarter. The firm had revenue of $2.06 million for the quarter. TRxADE HEALTH had a negative net margin of 78.18% and a negative return on equity of 69.22%.

TRxADE HEALTH Announces Dividend

The company also recently declared a dividend, which was paid on Friday, March 22nd. Shareholders of record on Monday, March 18th were paid a dividend of $8.00 per share. The ex-dividend date of this dividend was Monday, March 25th.

Institutional Investors Weigh In On TRxADE HEALTH

An institutional investor recently bought a new position in TRxADE HEALTH stock. Barclays PLC acquired a new stake in shares of TRxADE HEALTH, Inc. (NASDAQ:MEDS) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 4,801 shares of the company’s stock, valued at approximately $63,000. Barclays PLC owned about 0.71% of TRxADE HEALTH as of its most recent filing with the Securities and Exchange Commission. 5.68% of the stock is currently owned by hedge funds and other institutional investors.

About TRxADE HEALTH

TRxADE HEALTH, Inc operates as a health services IT company in the United States. The company focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, prescription journey, and patient engagement. It operates the TRxADE drug procurement marketplace, which offers price transparency, purchasing capabilities, and other value-added services; and offers patient centric telehealth services under the Bonum Health brand name.